A share price of Health Catalyst Inc [HCAT] is currently trading at $3.28, up 7.19%. Until recently, the best way to gauge how the stock has performed was to look at its short-term value. The HCAT shares have gain 12.33% over the last week, with a monthly amount drifted -14.81%, and not seem to be holding up well over a long-time horizon.
From an analyst’s perspective:
Health Catalyst Inc [NASDAQ: HCAT] stock has seen the most recent analyst activity on August 11, 2025, when Citigroup downgraded its rating to a Neutral. Previously, Cantor Fitzgerald downgraded its rating to Neutral on August 08, 2025, and kept the price target unchanged to $4. On June 17, 2025, downgrade downgraded it’s rating to Neutral. Evercore ISI downgraded its rating to a In-line. KeyBanc Capital Markets upgraded its rating to a Overweight but $9 remained the price target by the analyst firm on January 08, 2025. KeyBanc Capital Markets downgraded its rating to Sector Weight for this stock on April 10, 2024. In a note dated January 03, 2024, Evercore ISI upgraded an Outperform rating on this stock but restated the target price of $11.
Health Catalyst Inc experienced fluctuations in its stock price throughout the past year between $2.52 and $9.24. Currently, Wall Street analysts expect the stock to reach $5 within the next 12 months. Health Catalyst Inc [NASDAQ: HCAT] shares were valued at $3.28 at the most recent close of the market. An investor can expect a potential return of 52.44% based on the average HCAT price forecast.
Analyzing the HCAT fundamentals
Trailing Twelve Months sales for Health Catalyst Inc [NASDAQ:HCAT] were 316.09M which represents 6.35% growth. Gross Profit Margin for this corporation currently stands at 0.45% with Operating Profit Margin at -0.28%, Pretax Profit Margin comes in at -0.32%, and Net Profit Margin reading is -0.32%. To continue investigating profitability, this company’s Return on Assets is posted at -0.16, Equity is -0.28 and Total Capital is -0.17. An extended analysis of the company’s primary financial structure reveals a debt-to-equity ratio of0.5.
Before buying any particular stock, readers tend to pay close attention to the indicators that support and create resistance. The company’s stock is currently sitting at 3.14 points at the first support level, and at 2.99 for the second support level. However, for the 1st resistance point, the stock is sitting at 3.37, and for the 2nd resistance point, it is at 3.45.
Ratios To Look Out For
To put it in perspective, the Current Ratio for Health Catalyst Inc [NASDAQ:HCAT] is 1.81. As well, the Quick Ratio is 1.81, while the Cash Ratio is 0.51. Considering the valuation of this stock, the price to sales ratio is 0.73, the price to book ratio is 0.66.
Transactions by insiders
Recent insider trading involved Landry Benjamin, General Counsel, that happened on Jun 05 ’25 when 6057.0 shares were sold. Officer, BENJAMIN LANDRY completed a deal on Jun 05 ’25 to buy 6057.0 shares. Meanwhile, Officer Benjamin Landry bought 3255.0 shares on Jun 02 ’25.
